Nick Kunze of Sanlam Private Wealth on Nasdaq volatility and whether the SA Inc rally will continue. Afrox CEO Schalk Venter on results to end June. A look at the used-car market as Transaction Capital buys a stake in WeBuyCars.

‘Overall, we were a net sufferer at the hands of Covid-19,’ states deputy CE Gus Attridge.

Aspen's full-year headline earnings per share rose 9% to R12.68.

Anchor Capital's Deryck Janse van Rensburg on SA Inc shares and Aspen's results. Mustek CEO David Kan talks results and the business post lockdown. Bastian Teichgreeber from Prescient discusses a systematic investment approach.

Stephen Saad – CEO, Aspen Pharmacare

'The proceeds from the transaction will be used to reduce the group's debt,' Aspen said

Main stock index extends gains for a second day, rising 0.7%.

Impairments for the year were expected to be approximately R1.5 billion, as compared with R3.8 billion seen last year.

Foreigners remained net sellers of South African stocks for a 10th day on Friday.

Petri Redelinghuys of Herenya Capital talks the Top40 and takes a look at Aspen. Cotton On's Phil Marais on the logistics of online retail and how it can benefit brick and mortar stores. Brikor CEO Garnett Parkin on having the company's JSE suspension lifted and why bricks are flying out of its factories.

Finance Minister Tito Mboweni is set to table government’s supplementary 2020 budget at 3pm

Aspen can ramp up output if there is a need - CEO.

Government, Aspen in touch to source drug for all of Africa.

FNB Wealth and Investment's Chantal Marx discusses the further opening of the economy and Aspen's share price reacting to hopes of a new Covid-19 wonder drug. Gary Booysen of Rand Swiss on trader vs investor. FlySafair's CEO Elmar Conradie gives an update following the resumption of flights.

On positive Covid-19 drug trial.